BUKRINSKY; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for BUKRINSKY; Michael.The latest application filed is for "compositions and methods to treat viral infection and co-morbidities".

Company Profile

5.12.11

BUKRINSKY; Michael - Washington D.C. DC
BUKRINSKY; Michael - Potomac MD
- Potomac MD US
Bukrinsky; Michael - Glen Head NY
Bukrinsky, MIchael - Glenwood Landing NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions And Methods To Treat Viral Infection And Co-morbidities App 20220177559 - MILLER; Yury ; et al.	2022-06-09
Compounds Inhibiting Nef-calnexin Interaction App 20210405029 - ADZHUBEI; Alexei ; et al.	2021-12-30
Compounds inhibiting Nef-calnexin interaction Grant 11,131,661 - Adzhubei , et al. September 28, 2	2021-09-28
Compounds Inhibiting Nef-calnexin Interaction App 20200340977 - ADZHUBEI; Alexei ; et al.	2020-10-29
Compounds inhibiting Nef-calnexin interaction Grant 10,684,274 - Adzhubei , et al.	2020-06-16
Compounds Inhibiting Nef-calnexin Interaction App 20190033297 - ADZHUBEI; Alexei ; et al.	2019-01-31
Cyclosporin derivatives Grant 9,453,051 - Fischer , et al. September 27, 2	2016-09-27
Cyclosporin Derivatives App 20140316104 - Fischer; Gunter ; et al.	2014-10-23
Cyclosporin derivatives Grant 8,618,065 - Fischer , et al. December 31, 2	2013-12-31
Cyclosporin derivatives Grant 08618065 -	2013-12-31
Method of suppressing human immunodeficiency virus (HIV) replication in a subject by administering a liver X receptor (LXR) agonist Grant 8,470,526 - Bukrinsky , et al. June 25, 2	2013-06-25
Cyclosporin Derivatives App 20120196749 - Fischer; Gunter ; et al.	2012-08-02
Treatment of HIV-1-infected individuals to reduce risk of coronary artery disease and suppress virus replication App 20110033446 - Bukrinsky; Michael ; et al.	2011-02-10
Guanylhydrazones useful for treating diseases associated with T cell activation Grant 7,741,372 - Tracey , et al. June 22, 2	2010-06-22
Compositions And Methods For Diagnosis And Treatment Of Chronic Inflammatory Diseases App 20090258024 - BUKRINSKY; MICHAEL ; et al.	2009-10-15
Guanylhydrazones useful for treating diseases associated with T cell activation App 20040171695 - Tracey, Kevin J. ; et al.	2004-09-02
Guanylhydrazones useful for treating diseases associated with T cell activation Grant 6,673,777 - Tracey , et al. January 6, 2	2004-01-06
Anti-Viral Treatment With Pertussis Toxin B Oligomer App 20020172687 - Bukrinsky, MIchael ; et al.	2002-11-21
HIV matrix protein tyrosine position 29 pocket binders Grant 5,849,793 - Pan , et al. December 15, 1	1998-12-15
Treatment of HIV-Infection by interfering with host cell cyclophilin receptor activity Grant 5,840,305 - Bukrinsky , et al. November 24, 1	1998-11-24

Company Registrations

NCAGE Code	43YT5	BUKRINSKY MICHAEL
CAGE Code	43YT5	BUKRINSKY, MICHAEL

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.